RankingsPricing
  1. JP-listed companies
  2. COSMOS Pharmaceutical Corporation
  3. Financials
  4. Repayments of term debt

COSMOS Pharmaceutical Corporation【JP:3349】

Market cap
¥611.4B
P/E ratio
19.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRepayments of term debt (Million JPY)YoY (%)
May 31, 2025-5,082+59.16%
May 31, 2024-3,193+96.13%
May 31, 2023-1,628+9.56%
May 31, 2022-1,486+0.00%
May 31, 2021-1,486+0.00%
May 31, 2020-1,486-53.55%
May 31, 2019-3,199-28.69%
May 31, 2018-4,486-9.39%
May 31, 2017-4,951-1.10%
May 31, 2016-5,006+99.05%
May 31, 2015-2,515+69.25%
May 31, 2014-1,486

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)